Detailed information for compound 166540

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 414.452 | Formula: C22H26N2O6
  • H donors: 3 H acceptors: 4 LogP: 2.7 Rotable bonds: 10
    Rule of 5 violations (Lipinski): 1
  • SMILES: CC(C[C@@H](C(=O)N[C@H]1CC(=O)OC1O)NC(=O)COc1ccc2c(c1)cccc2)C
  • InChi: 1S/C22H26N2O6/c1-13(2)9-17(21(27)24-18-11-20(26)30-22(18)28)23-19(25)12-29-16-8-7-14-5-3-4-6-15(14)10-16/h3-8,10,13,17-18,22,28H,9,11-12H2,1-2H3,(H,23,25)(H,24,27)/t17-,18-,22?/m0/s1
  • InChiKey: BSVUOPHXZOKMKE-KJMDXERQSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens caspase 1, apoptosis-related cysteine peptidase Starlite/ChEMBL References
Homo sapiens caspase 7, apoptosis-related cysteine peptidase Starlite/ChEMBL References
Homo sapiens caspase 6, apoptosis-related cysteine peptidase Starlite/ChEMBL References
Homo sapiens caspase 8, apoptosis-related cysteine peptidase Starlite/ChEMBL References
Homo sapiens caspase 3, apoptosis-related cysteine peptidase Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Echinococcus granulosus caspase 3 Get druggable targets OG5_130238 All targets in OG5_130238
Echinococcus granulosus caspase Get druggable targets OG5_130238 All targets in OG5_130238
Echinococcus multilocularis caspase Get druggable targets OG5_130238 All targets in OG5_130238
Echinococcus granulosus caspase 3 apoptosis cysteine peptidase Get druggable targets OG5_130238 All targets in OG5_130238
Echinococcus multilocularis caspase 3 Get druggable targets OG5_130238 All targets in OG5_130238
Schistosoma japonicum ko:K02187 caspase 3, apoptosis-related cysteine protease, putative Get druggable targets OG5_130238 All targets in OG5_130238
Schistosoma japonicum ko:K04397 caspase 7, apoptosis-related cysteine protease, putative Get druggable targets OG5_130238 All targets in OG5_130238
Schistosoma mansoni caspase-7 (C14 family) Get druggable targets OG5_130238 All targets in OG5_130238
Schistosoma mansoni caspase-3 (C14 family) Get druggable targets OG5_130238 All targets in OG5_130238
Echinococcus multilocularis caspase 3, apoptosis cysteine peptidase Get druggable targets OG5_130238 All targets in OG5_130238

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Echinococcus granulosus caspase 8 caspase 1, apoptosis-related cysteine peptidase 383 aa 312 aa 26.6 %
Brugia malayi Cell death protein 3 precursor caspase 6, apoptosis-related cysteine peptidase 293 aa 270 aa 34.4 %
Brugia malayi Cell death protein 3 precursor caspase 3, apoptosis-related cysteine peptidase 277 aa 253 aa 38.7 %
Brugia malayi Cell death protein 3 precursor caspase 7, apoptosis-related cysteine peptidase 303 aa 256 aa 37.1 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Plasmodium falciparum heat shock protein 90 0.2218 1 1
Onchocerca volvulus Heat shock protein 75 kDa, mitochondrial homolog 0.1981 0.8753 1
Toxoplasma gondii heat shock protein HSP90 0.2218 1 1
Trichomonas vaginalis heat shock protein, putative 0.2218 1 1
Echinococcus granulosus heat shock protein 0.2218 1 1
Schistosoma mansoni endoplasmin 0.2218 1 1
Trypanosoma brucei heat shock protein, putative 0.2218 1 1
Leishmania major heat shock protein 83-1 0.2218 1 1
Echinococcus granulosus endoplasmin 0.1891 0.828 0.828
Schistosoma mansoni pyruvate dehydrogenase 0.04 0.0449 0.0449
Trypanosoma cruzi Heat shock protein 83, putative 0.2218 1 1
Plasmodium vivax heat shock protein, putative 0.1132 0.4292 0.4023
Leishmania major heat shock protein 83-1 0.2218 1 1
Plasmodium vivax endoplasmin, putative 0.2218 1 1
Leishmania major heat shock protein 83-1 0.2218 1 1
Trypanosoma brucei heat shock protein, putative 0.2218 1 1
Plasmodium falciparum endoplasmin, putative 0.1459 0.6012 0.5824
Leishmania major heat shock protein 83-1 0.2218 1 1
Mycobacterium ulcerans heat shock protein 90 0.1891 0.828 1
Entamoeba histolytica heat shock protein 90, putative 0.2218 1 1
Giardia lamblia Heat shock protein HSP 90-alpha 0.2218 1 1
Trichomonas vaginalis endoplasmin, putative 0.1459 0.6012 0.5824
Echinococcus granulosus heat shock protein 90 0.2218 1 1
Echinococcus multilocularis DNA topoisomerase 2 alpha 0.04 0.0449 0.0449
Loa Loa (eye worm) heat shock protein 75 0.1981 0.8753 0.8694
Trypanosoma brucei heat shock protein 90, putative 0.2218 1 1
Toxoplasma gondii heat shock protein 75, putative 0.1981 0.8753 0.8694
Echinococcus multilocularis Pyruvate dehydrogenase (lipoamide) kinase 0.04 0.0449 0.0449
Trichomonas vaginalis heat shock protein, putative 0.1059 0.391 0.3624
Mycobacterium tuberculosis Probable chaperone protein HtpG (heat shock protein) (HSP90 family protein) (high temperature protein G) 0.1891 0.828 1
Plasmodium vivax heat shock protein 86, putative 0.2218 1 1
Leishmania major heat shock protein 83-1 0.2218 1 1
Echinococcus multilocularis endoplasmin 0.1891 0.828 0.828
Entamoeba histolytica heat shock protein 90, putative 0.2218 1 1
Leishmania major heat shock protein, putative 0.1981 0.8753 0.8694
Echinococcus granulosus heat shock protein 90 0.1818 0.7899 0.7899
Leishmania major heat shock protein 83-1 0.2218 1 1
Wolbachia endosymbiont of Brugia malayi heat shock protein 90 0.1891 0.828 1
Chlamydia trachomatis DNA gyrase subunit B 0.04 0.0449 0.5
Schistosoma mansoni heat shock protein 0.1981 0.8753 0.8753
Schistosoma mansoni DNA topoisomerase II 0.04 0.0449 0.0449
Schistosoma mansoni heat shock protein 0.2218 1 1
Echinococcus multilocularis heat shock protein 75 kDa, mitochondrial 0.1981 0.8753 0.8753
Echinococcus multilocularis heat shock protein 0.2218 1 1
Echinococcus granulosus Pyruvate dehydrogenase lipoamide kinase 0.04 0.0449 0.0449
Echinococcus granulosus heat shock protein 75 kDa mitochondrial 0.1981 0.8753 0.8753
Trypanosoma cruzi heat shock protein 90, putative 0.1818 0.7899 0.78
Treponema pallidum heat shock protein 90 0.1891 0.828 1
Giardia lamblia Heat shock protein HSP 90-alpha 0.1818 0.7899 0.78
Trichomonas vaginalis heat shock protein, putative 0.1891 0.828 0.8199
Trypanosoma cruzi heat shock protein 85, putative 0.2218 1 1
Leishmania major heat shock protein 83-1 0.2218 1 1
Trypanosoma cruzi heat shock protein 85, putative 0.1818 0.7899 0.78
Leishmania major heat shock protein 83-1 0.2218 1 1
Mycobacterium leprae PROBABLE CHAPERONE PROTEIN HTPG (HEAT SHOCK PROTEIN) (HSP90 FAMILY PROTEIN) (HIGH TEMPERATURE PROTEIN G) 0.1891 0.828 1
Trypanosoma brucei heat shock protein, putative 0.2218 1 1
Brugia malayi heat shock protein 90 0.2218 1 1
Leishmania major heat shock protein 83-1 0.2218 1 1
Leishmania major heat shock protein 83-1 0.2218 1 1
Leishmania major heat shock protein 83-1 0.2218 1 1
Chlamydia trachomatis two component regulatory system sensor histidine kinase 0.04 0.0449 0.5
Trypanosoma brucei heat shock protein 84, putative 0.1981 0.8753 0.8694
Leishmania major heat shock protein 83-1 0.2218 1 1
Loa Loa (eye worm) heat shock protein 90 0.2218 1 1
Leishmania major heat shock protein 83-1 0.2218 1 1
Brugia malayi Hsp90 protein 0.1981 0.8753 0.8694
Trypanosoma brucei heat shock protein, putative 0.2218 1 1
Trypanosoma brucei heat shock protein, putative 0.2218 1 1
Leishmania major lipophosphoglycan biosynthetic protein, putative,heat shock protein 90, putative,glucose regulated protein 94, putative 0.1891 0.828 0.8199
Trypanosoma brucei heat shock protein, putative 0.2218 1 1
Leishmania major heat shock protein 83-1 0.2218 1 1
Leishmania major heat shock protein 83-1 0.2218 1 1
Echinococcus multilocularis Pyruvate dehydrogenase (lipoamide) kinase 0.04 0.0449 0.0449
Entamoeba histolytica 90 kDa heat shock protein, putative 0.1132 0.4292 0.4023
Trypanosoma cruzi heat shock protein 90, putative 0.1159 0.4438 0.4176
Plasmodium falciparum heat shock protein 90, putative 0.1132 0.4292 0.4023
Echinococcus granulosus DNA topoisomerase 2 alpha 0.04 0.0449 0.0449
Trypanosoma cruzi heat shock protein 85, putative 0.2218 1 1
Trypanosoma cruzi heat shock protein 90, putative 0.2218 1 1
Echinococcus multilocularis heat shock protein 90 0.2218 1 1
Trypanosoma brucei heat shock protein 90, putative 0.2218 1 1
Schistosoma mansoni endoplasmin 0.2218 1 1
Leishmania major heat shock protein 83-1 0.2218 1 1
Giardia lamblia Grp94/Hsp90 0.1891 0.828 0.8199
Trypanosoma brucei heat shock protein, putative 0.2218 1 1
Trypanosoma cruzi heat shock protein 85, putative 0.2218 1 1
Echinococcus multilocularis heat shock protein 90 0.1818 0.7899 0.7899
Toxoplasma gondii heat shock protein 90, putative 0.2218 1 1
Trichomonas vaginalis heat shock protein, putative 0.1459 0.6012 0.5824
Trypanosoma brucei Heat shock protein 83, putative 0.2218 1 1
Trypanosoma cruzi heat shock protein, putative 0.1981 0.8753 0.8694
Loa Loa (eye worm) endoplasmin 0.2218 1 1
Echinococcus granulosus heat shock protein heat shock protein 90 alpha 0.1818 0.7899 0.7899
Trypanosoma brucei heat shock protein, putative 0.2218 1 1
Schistosoma mansoni heat shock protein 0.2218 1 1
Toxoplasma gondii Hsp90 domain-containing protein 0.1132 0.4292 0.4023
Leishmania major heat shock protein 83-1 0.2218 1 1
Plasmodium vivax heat shock protein 90, putative 0.1981 0.8753 0.8694
Trichomonas vaginalis heat shock protein, putative 0.1818 0.7899 0.78
Plasmodium falciparum heat shock protein 90, putative 0.1908 0.8371 0.8295
Trichomonas vaginalis heat shock protein, putative 0.1891 0.828 0.8199
Chlamydia trachomatis DNA gyrase subunit B 0.04 0.0449 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 0.94 uM Inhibitory concentration of compound required against Caspase-3 enzyme compared to acylated dipeptides ChEMBL. 12270186
IC50 (binding) = 0.94 uM Inhibitory concentration of compound required against Caspase-3 compared to acylated dipeptides ChEMBL. 12270185
IC50 (binding) = 0.94 uM Inhibitory concentration of compound required against Caspase-3 enzyme compared to acylated dipeptides ChEMBL. 12270186
IC50 (binding) = 0.94 uM Inhibitory concentration of compound required against Caspase-3 compared to acylated dipeptides ChEMBL. 12270185
IC50 (binding) = 0.944 uM Inhibitory concentration against caspase-3 ChEMBL. 12270185
IC50 (binding) = 0.944 uM Inhibitory concentration against caspase-3 ChEMBL. 12270185
IC50 (binding) = 8.87 uM Inhibitory concentration of compound required against Caspase-7 enzyme compared to acylated dipeptides ChEMBL. 12270186
IC50 (binding) = 8.87 uM Inhibitory concentration against caspase-7 ChEMBL. 12270185
IC50 (binding) = 8.87 uM Inhibitory concentration of compound required against Caspase-7 compared to acylated dipeptides ChEMBL. 12270185
IC50 (binding) = 8.87000000000001 uM Inhibitory concentration of compound required against Caspase-7 enzyme compared to acylated dipeptides ChEMBL. 12270186
IC50 (binding) = 8.87000000000001 uM Inhibitory concentration against caspase-7 ChEMBL. 12270185
IC50 (binding) = 8.87000000000001 uM Inhibitory concentration of compound required against Caspase-7 compared to acylated dipeptides ChEMBL. 12270185
IC50 (binding) = 10 uM Inhibitory concentration of compound required against Caspase-1 enzyme compared to acylated dipeptides ChEMBL. 12270186
IC50 (binding) = 10 uM Inhibitory concentration of compound required against Caspase-8 enzyme compared to acylated dipeptides ChEMBL. 12270186
IC50 (binding) = 10 uM Inhibition of caspase-1 ChEMBL. 12270185
IC50 (binding) > 10 uM Inhibitory concentration against caspase-8 ChEMBL. 12270185
IC50 (binding) = 10 uM Inhibitory concentration of compound required against Caspase-1 compared to acylated dipeptides ChEMBL. 12270185
IC50 (binding) = 10 uM Inhibitory concentration of compound required against Caspase-8 compared to acylated dipeptides ChEMBL. 12270185
IC50 (binding) = 10 uM Inhibitory concentration of compound required against Caspase-1 enzyme compared to acylated dipeptides ChEMBL. 12270186
IC50 (binding) = 10 uM Inhibitory concentration of compound required against Caspase-8 enzyme compared to acylated dipeptides ChEMBL. 12270186
IC50 (binding) = 10 uM Inhibition of caspase-1 ChEMBL. 12270185
IC50 (binding) > 10 uM Inhibitory concentration against caspase-8 ChEMBL. 12270185
IC50 (binding) = 10 uM Inhibitory concentration of compound required against Caspase-1 compared to acylated dipeptides ChEMBL. 12270185
IC50 (binding) = 10 uM Inhibitory concentration of compound required against Caspase-8 compared to acylated dipeptides ChEMBL. 12270185
IC50 (binding) = 18.56 uM Inhibitory concentration of compound required against Caspase-6 enzyme compared to acylated dipeptides ChEMBL. 12270186
IC50 (binding) = 18.56 uM Inhibitory concentration required against caspase-6 ChEMBL. 12270185
IC50 (binding) = 18.56 uM Inhibitory concentration of compound required against Caspase-6 compared to acylated dipeptides ChEMBL. 12270185
IC50 (binding) = 18.56 uM Inhibitory concentration of compound required against Caspase-6 enzyme compared to acylated dipeptides ChEMBL. 12270186
IC50 (binding) = 18.56 uM Inhibitory concentration required against caspase-6 ChEMBL. 12270185
IC50 (binding) = 18.56 uM Inhibitory concentration of compound required against Caspase-6 compared to acylated dipeptides ChEMBL. 12270185

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

2 literature references were collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.